论文部分内容阅读
目的探讨腹腔热灌注治疗腹腔转移癌的疗效,并分析不同原发病疗效的差别。方法总结河南科技大学第一附属医院自2013年3月至2015年3月治疗的腹腔转移癌治疗的临床资料,共254例,包括胃癌、肠癌、卵巢癌、肝胆系统肿瘤。结合腹水控制情况及并发症情况,分析疗效。结果其中治疗前后腹水控制良好,有统计学意义,除原发肝胆系统肿瘤治疗效果较差,其余病种控制较好。结论腹腔热灌注治疗腹腔转移癌疗效可,安全性好,建议临床择病种使用。
Objective To investigate the efficacy of intraperitoneal hyperthermic perfusion in the treatment of peritoneal metastases and to analyze the differences in efficacy between different primary diseases. Methods The clinical data of 254 cases of peritoneal metastases treated in the First Affiliated Hospital of Henan University of Science and Technology from March 2013 to March 2015 were summarized, including gastric cancer, intestinal cancer, ovarian cancer and hepatobiliary system tumors. Combined with ascites control and complications, analysis of efficacy. Results Among them, the control of ascites before and after treatment was good and statistically significant except for the treatment of primary liver and gallbladder tumors. The control of other diseases was better. Conclusion Intraperitoneal hyperthermic perfusion in the treatment of intraperitoneal metastatic cancer can be effective, safe, it is recommended to use clinical options.